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T h eb i b l i c a lb a l mo fG i l e a d( Commiphora gileadensis) was investigated in this study for anticancerous activity against tumor cell
lines. The results obtained from ethanol-based extracts and from essential oils indicated that β-caryophyllene (trans-(1R,9S)-8-
methylene-4,11,11-trimethylbicyclo[7.2.0]undec-4-ene) is a key component in essential oils extracted from the balm of Gilead. β-
Caryophyllene can be found in spice blends, citrus ﬂavors, soaps, detergents, creams, and lotions, as well as in a variety of food and
beverage products, and it is known for its anti-inﬂammatory, local anaesthetic, and antifungal properties. It is also a potent cyto-
toxiccompoundoverawiderangeofcelllines.Inthecurrentpaper,wefoundthatCommiphoragileadensisstemextractsandessen-
tial oil have an antiproliferative proapoptotic eﬀect against tumor cells and not against normal cells. β-caryophyllene caused a
potent induction of apoptosis accompanied by DNA ladder and caspase-3 catalytic activity in tumor cell lines. In summary, we
showed that C. gileadensis stems contain an apoptosis inducer that acts, in a selective manner, against tumor cell lines and not
against normal cells.
1.Introduction
For a normal living cell to replicate accurately, it must go
through several processes: precisely reproduce its DNA, pro-
duce suﬃcient cellular organelles, membranes, and so forth,
to enable the survival of the daughter cells, and divide its
DNA, cytoplasm, and organelles equally to form two func-
tioning daughter cells [1–3]. These processes are part of a
well-controlled equilibrium which exists between cell pro-
liferation and cell death, two stages of the cell cycle that have
become appreciated targets for intervention against cancer
as the cancerous process results from an imbalance between
the two [1]. This imbalance is linked with changes in the
cell’s response to signals from within. These signals include:
self-suﬃciency in growth signals, insensitivity to growth-
inhibitory (antigrowth) signals and limitless replicative
potential (over proliferation), sustained angiogenesis, tissue
invasion, metastasis, and evasion of apoptosis. Each of these
physiologic changes occurs during tumor development [1, 3,
4].
Apoptosis, the programmed cell death, comprises two
main phases: a commitment to cell death followed by an exe-
cution phase [5]. The apoptotic process is a cascade reaction,
carried out and regulated by specialized cellular machinery,
a family of cysteine proteases called caspases. The appea-
rance of these caspases seems to be the biochemical event
that deﬁnes a cellular response as apoptosis more than any
other[6].Thecaspasefamilyisdividedintotwo:theinitiator2 Evidence-Based Complementary and Alternative Medicine
Figure 1: C. gileadensis leaves and fruits. Photo taken in Ein Gedi’s
botanical gardens. Photos taken by Shelef Oren.
Figure 2: A drop of C. gileadensis resin on a C. gileadensis leaf.
Photo taken in Ein Gedi’s botanical gardens. Photos taken by Shelef
Oren.
caspases (caspase-8 and caspase-9) and the executioner cas-
pases(caspase-3,-6,and-7)[7].Anapoptoticdeathstimulus
(stimuli is plural) activates the initiator caspases which, in
turn, activate the executioner caspases. The active execution-
ers promote apoptosis by cleaving cellular substrates, which
induces the morphological and biochemical features of apo-
ptosis [8–10].
In modern cancer research, the isolation of active com-
pounds from natural products for drug use has reached an
all-time high in modern westernized medicine, resulting in
most of the existing anticancer drugs [11, 12]. These drugs
are aimed speciﬁcally at various components of the intracel-
lular signal transduction pathways controlling cell cycle, pro-
grammed cell death (apoptosis), or angiogenesis [9]. These
naturallyderivedproductsareoﬀeringtheworldofmedicine
a great opportunity to evaluate new chemical classes of
anticanceragents,aswellasnovelmechanismsofaction[13].
In this study, we describe a new apoptosis-inducing
agent, β-caryophyllene (trans-(1R,9S)-8-methylene-4,11,11-
trimethylbicyclo[7.2.0]undec-4-ene) which was found to be
a major component in the essential oil derived from C. gile-
adensis. β-caryophyllene, a compound found in spice blends,
citrus ﬂavors, soaps, detergents, creams and lotions, and also
in a variety of food and beverage products, [14, 15] is known
for its anti-inﬂammatory, local anaesthetic, and antifungal
properties [16–18]. In experiments conducted on tumor cell
lines, β-caryophyllene has been reported to have a potent
cytotoxic activity over a wide range of cell lines [19, 20].
Commiphora gileadensis (L.) (Syn C. opobalsamum, Amy-
ris gileadensis, Amyris opobalsamum, Balsamodendron opo-
balsamum [21]) is a member of the highly studied and com-
mercially used resinous plant family Burseraceae, compris-
ing, among others, the biblical frankincense and myrrh [22].
It is native to southwest Arabia and Somaliland, where it
grows in a thorn-bush formation under arid tropical condi-
tions, often accompanied by shrubs and trees such as Balani-
tes aegyptiaca and species of Maerua, Ziziphus [23]. It is a
thornless shrub (1.5m high) or small tree (5m high) with
a reddish or grayish bark which grows in hot deserts and
semideserts. Its white ﬂowers create small clusters and pro-
duce ovoid or ellipsoid, smooth, glabrous fruits which con-
tain a fragrant yellow seed that brightens in color as the seed
matures and dries [23–25] (Figures 1 and 2). After receiving
a specimen sheet from his student Peter Forssk˚ al in Yemen,
Linnaeus gave it the name Commiphora gileadensis,i nc o n -
nection with the Bible’s “balm of Gilead” (Genesis 37:25,
Jeremiah 46:11, and Jeremiah 8:22). The specimen was sent
with a letter dated June 3rd 1763, in which Forssk˚ al wrote
about his discovery of the “balm of Gilead” [21, 25, 26].
Ancient writers, such as Josephus Flavius, Pliny the elder,
Pedanius Dioscorides, and Gaius Tacitus, highly praised it
(the balm (balsam) tree of Judea) for its use as holy oil and in
perfumes, but also considered it as a cure for many diseases
[23, 27]. The shoots of C. gileadensis a r eu s e di nf o l km e d i -
cine to treat various illnesses [28–33]. However, the history
and elaborate folk medicinal value of the species has not yet
been put to the test and remains generally overlooked by
modern science.
In this manuscript, we describe the antiproliferative and
proapoptotic eﬀect of the C. gileadensis-derived essential oil
and its derivative compound β-caryophyllene.
2.MaterialsandMethods
2.1. Plant Material. Commiphora gileadensis cuttings were
obtained from the Dead Sea Ein Gedi Botanical Garden
located in kibbutz Ein Gedi, the Dead Sea, Israel (31◦ 27 N,
35◦ 23 E)(plantsoriginatedfromtheChelseaPhysicGarden,
66 Royal Hospital Road, Chelsea, London, UK). In Ein
Gedi’s botanical gardens, the plants were grown in the ﬁeld
in sandy soil and drip irrigated with tap water (drinking
water originating from Ein Gedi’s spring water). Each plant
received 10 liters every four days. Between November and
March, the plants were watered every ﬁve days. The plants
wereidentiﬁedasCommiphoragileadensis(L.)(Burseraceae),
by Dr. Shimon Rachmilevitch from the Department of
Biotechnology and Agriculture in Arid Land in Ben Gurion
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2.2. Extraction. Commiphora gileadensis stem extracts were
prepared as follows.
(1) Ethanolic stem extracts: stems were dried at 40◦Cf o r
three days and stem powder was suspended in tubes
with ethanol 96% (EtOH-FRUTAROM) at a ratio
of 200μg/mL which were incubated overnight at
roomtemperature(25◦C),followedbycentrifugation
(13,000 revolutions per minute (rpm)). The super-
natant (the extract) was moved to another tube and
kept at −20◦C until used.
(2) MTBE extraction for volatiles analysis: plant stems
were extracted with methyl-tert-butyl ether (MTBE),
containing 10mg/mL isobutylbenzene as an internal
standard, for 24h with gentle shaking at room tem-
perature [34].
2.3. Chemical Compounds
(i) β-Caryophyllene: (−)-trans-caryophyllene, syn. β-
Caryophyllene, trans-(1R,9S)-8-methylene-4,11,11-
trimethylbicyclo[7.2.0]undec-4-ene (C15H24), was
purchased from Sigma-Aldrich, Inc. 204.35g/mol,
≥98.5% pure, catalog number 22075.
(ii) Citral: syn. 3,7-dimethyl-2,6-octadienal (C10H16O),
40:60% of geranial and neral mixture was used
in this research as a positive control [35]. Purcha-
sed from Sigma-Aldrich, Inc (Fluka). 152.24g/mol,
≥95% pure, catalog number 27450.
(iii) Staurosporine (STS): syn. antibiotic AM-2282 (C28
H26N4O3), from Streptomyces sp., was used in this
research as a positive control. Purchased from Sigma-
Aldrich, Inc. 466.53g/mol, ≥95% pure, catalog num-
ber S4400.
2.4. Cell Culture. The following cell lines were used in this
study.
BS-24-1: mouse lymphoma cell line (T cells, [36]).
MoFir:Epstein-Barrvirus-transformedhumanBlym
phocytes generated in the laboratory by transforma-
tion of a human B cell from an anonymous donor
(see below).
FB: normal human skin ﬁbroblasts (BJ cells, [36]).
BS-24-1, and MoFir were grown in a Roswell Park
Memorial Institute medium (RPMI, Biological Industries
Beit Haemek) supplemented with 2mML−1 glutamine (Bio-
logical Industries Beit Haemek), 10% fetal bovine serum
(FBS, Biological Industries Beit Haemek), 100 U/mL peni-
cillin, and 100mg/mL streptomycin (Biological Industries
Beit Haemek). FBs was grown in a Dulbecco/Vogt modi-
ﬁed Eagle’s minimal essential medium (DMEM-Biological
Industries Beit Haemek) supplemented with 2mML−1 glu-
tamine,20%FBS,100U/mLpenicillinand100mg/mLstrep-
tomycin. All the cells were maintained at 37◦Ci naw a t e r -
saturated atmosphere of 5% CO2.
2.5. EBV Transformation. To establish the MoFir cells, B cells
from whole blood were separated by Ficoll-Hypaque density
gradientcentrifugation.ThecellswereinfectedwiththeB95-
8 strain of the Epstein-Barr virus. The RPMI medium (Bio-
logicalIndustriesBeitHaemek)wasusedforcellculture.The
EBVBlymphocytecelllinewasmaintainedinRPMI,supple-
mented with 10% FBS, 100U/mL penicillin, and 100mg/mL
streptomycin. The culture was maintained at 37◦Ci n5 %
CO2 atmosphere.Themediumwaschangedeverythreedays.
2.6. GC-MS Analysis. One μL from the extracted samples
was analyzed in a computerized GC-MS (GC-6890N) equip-
pedwithamassselective(MS)—5973network(electronion-
ization 70eV) detector of Agilent Technologies (CA, USA).
A capillary column, Rtx-5Sil MS (Restek Corporation, State
College,PA,USA)(30m×0.25mm)i.d×0.25μmsilica,was
installed into the GC-MS. The carrier gas, helium (He), was
in a mode of constantﬂow of1mL/min. The extraction sam-
ples were introduced into the column in a “splitless” mode
while the oil and SPME samples were introduced in a “split”
mode ratio of 1:50. Temperatures were set as follows: the
injector’s temperature was 250◦C, and both the transfer line
and detector’s temperature were 280◦C. The columns’ tem-
perature gradient was set at 50◦C for 1 minute, with addi-
tions of 5◦C per minute up to 260◦C, and then 260◦Cf o rt e n
minutes.
Component recognition was based on a comparison of
the retention time index (RI) of the components to com-
mercial standards and by comparison of the samples’ mass
spectrum with GC-MS libraries: Adams 2001, NIST 98, and
QuadLib 1607.
2.7. Essential Oil Preparation. Essential oils of Commiphora
gileadensis (L.) (Burseraceae) (Gilead oil) were prepared as
described [34].
Three dilutions were examined in the experiment: 1:
20000, 10000, and 5000. Stock solutions of Gilead oil dilu-
tions were prepared by adding 1μL to 20, 10, and 5μL etha-
nol, respectively. 1μL from the stock solution was added into
the 1000μL cell growth medium.
2.8. Results Presentation. The results presented in this study
are from a representative experiment. A minimum of ﬁve
experiments were carried out with each compound, and the
samples were analyzed in triplicates.
Cell death was assessed by the incubation of cells with
Tetrazolium bromide salt MTT. The production of formazan
was monitored using an ELISA reader at a wavelength of
450nm. Cytotoxicity in the compound-treated culture was
expressed as follows:
%d e a t h= 100 ×
absorbance of compound-treated cell
absorbance of ethanol-treated cells

.
(1)
Apoptosis was induced by incubating the cell lines
with the compounds in their normal serum-supplemented
growth medium.4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Growth inhibitory eﬀect of ethanol-based Commiphora
gileadensis stem extract on two tumor cell lines. Extract concentra-
tions shown on x-axis are in μL/mL. The cells were plated at a con-
centration of 500,000 cells/mL and incubated with and without
stem extract for 17h. Control cells were treated with ethanol
(0.05%) alone.
The caspase-3 cellular activity assay was carried out ac-
cording to the manufacturer’s instructions. For measuring
the speciﬁc inhibition by Ac-DEVD-CHO, cell extracts were
preincubated with the inhibitor (0.05μM) for 10 minutes
beforetheadditionofthesubstrate.TheDNAladderanalysis
w a sp e r f o r m e da sd e s c r i b e db e f o r e[ 37].
3. Results
We ﬁrst investigated whether C. gileadensis extracts had anti-
proliferative eﬀects against tumor cell lines using the MTT
assay.Weevaluateditseﬀectonmouse(BS-24-1)andhuman
(MoFir) cell lines using ethanol- (EtOH-) based stem ex-
tracts. As shown in Figure 3, following 24h incubation of
cells with extracts, cell survival was 30 and 50% for BS-24-
1 cells and MoFir cells at 0.5μL/well, respectively. IC50 was
0.3125 and 2.5μL/mL, respectively.
Based on the latter results, we assessed the eﬀect of C.
gileadensis essential oil on tumor cell lines, comparing it to
two reference compounds: staurosporine (STS) and citral
[35]( Figure 4). Proliferative inhibition of Gilead oil incu-
bated with tumor cell lines for 2h showed concentration
dependency (Figure 4), and Gilead oil concentration of 1:
5000 killed 87% of BS-24-1 cells and 40% of MoFir cells,
suggesting that one or more of the components in the essen-
tial oil contributed to the tumor cell lines killing eﬀect. We
next separated and identiﬁed the Gilead oil volatiles
components using GC-MS. The compound list received
from the fractionation (Table 1) was composed mainly of
terpens from which we decided to focus on what was most
likelytobetheactivecompound,β-caryophyllene,knownfor
its cytotoxicity, anti-inﬂammatory, and antifungal activity
[16–20, 38]. To examine the eﬀect of β-caryophyllene, both
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Figure 4: Growth inhibitory eﬀect of C. gileadensis essential oil
on two tumor cell lines. The cells were plated at a concentration
of 500,000cells/mL and incubated with citral (3.1e − 4μM), STS
(2μM) and three concentrations of essential oil from C. gileadensis
(named here gilead oil) for 2h. Control cells were treated with
ethanol (0.05%) alone.
tumor cell lines were incubated for 2h with β-caryophyllene
while STS and Citral served as references (Figure 5). β-
Caryophyllene showed a concentration dependency of pro-
liferation inhibition and induced 85–90% cell killing in both
c e l ll i n e sa tc o n c e n t r a t i o n so f4 .8e − 4μM. These results
suggest that β-caryophyllene is the active compound within
the oil extract.
Incubation of human (MoFir) and mouse (BS-24-1)
tumor cell lines for 2h with β-caryophyllene (2.4e − 4μM)
resulted in the activation of the enzymatic activity of cas-
pase-3 (Figure 6). Pretreatment of Moﬁr and BS-24-1 cells
with the speciﬁc caspase-3 inhibitor, Ac-DEVD-CHO, inhib-
ited caspase-3 activity, indicating that the active enzyme in
the assay in both cell lines is indeed caspase-3 (Figure 7).
The property of β-caryophyllene as an inducer of cas-
pase-3 enzymatic activity was compared and found similar
to the reference compound citral (Figure 8).
A biochemical hallmark of apoptosis is the activation of
endonucleases, leading to the fragmentation of the genomic
DNA, which produces a characteristic ladder when separated
on an agarose gel electrophoresis [39]. When C. gileadensis
stem extracts were incubated with BS-24-1 for 24h, a DNA
ladder was observed (Figure 9). The incubation of C. gile-
adensis stem extracts with normal cells (FB) and MoFir for
24h produced a DNA ladder only in MoFir (the tumor
cell line, Figure 10). 24h incubation of Gilead oil with BS-
24-1 formed a similar pattern (Figure 11) that was repea-
ted following 2h treatment of BS-24-1 cells with β-cary-
ophyllene (Figure 12). These results suggest that the C. gile-
adensis stem extract is an apoptosis inducer that acts inEvidence-Based Complementary and Alternative Medicine 5
Table 1: Composition of the essential oil from C. gileadensis leaves
and fruits collected in Ein Gedi’s botanical garden, on June 2nd,
2009.Generalchemicalproﬁleandthecontentpercentageofindivi-
dual components are presented.
Components % content in oil
α-Thujene 0.64
α-Pinene 7.21
Camphene 0.18
Sabinene 21.11
β-Pinene 0.90
α-Terpinene —
Para-Cymene 0.16
Limonene 0.27
β-Phellandrene 0.80
(Z)-β-Ocimene 0.34
(E)-β-Ocimene —
γ-Terpinene 2.75
cis-Sabinene hydrate 0.16
Terpinolene —
Trans-Sabinene hydrate 0.20
allo-Ocimene 0.28
Borneol —
Terpinen-4-ol 1.26
α-Terpineol 0.33
n-Decanal —
Bornyl acetate 1.66
Bicycloelemene 2.21
α-Ylangene 0.63
β-Cubebene 0.10
β-Elemene 0.53
(E)-Jasmone 0.17
β-Caryophyllene 20.12
β-Copaene 1.85
6,9-Guaiadiene 0.43
Sesquiterpene hydrocarbone 0.77
Sesquiterpene hydrocarbone 0.69
Sesquiterpene hydrocarbone 1.29
α-Humulene 0.59
Dauca-5,8-diene 0.43
Germacrene D 19.62
Bicyclogermacrene 2.91
Sesquiterpene hydrocarbone 1.02
δ-Amorphene 1.35
γ-Cadinene 2.65
δ-Cadinene 0.37
Nerolidol 0.31
Germacrene D-4-ol 0.55
a selective manner against tumor cell lines and not against
normal cells.
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Figure 5: Growth inhibitory eﬀect of β-caryophyllene on two
tumor cell lines. The cells were plated at a concentration of
500,000cells/mL and incubated with citral (3.1e − 4μM), STS
(2μM)and threeβ-caryophyllene concentrations (2.4e−4, 4.8e−4,
and 9.6e − 4μM) for 2h. Control cells were treated with ethanol
(0.05%) alone.
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Figure 6: Apoptogenic eﬀects of β-caryophyllene on two tumor cell
lines. Enzymatic activity of diﬀerent cell lines incubated with β-
caryophyllene (2.4e−4μM)for2h.x-axisrepresentsthetimeofthe
enzymatic reaction in vitro in minutes.
4. Discussion
Commiphora gileadensis stem extracts and essential oil
showed antiproliferative proapoptotic eﬀects (exhibited via
DNA “ladder” and caspase-3 activation) in tumor cell lines,
while there was no apoptosis induction in normal cell lines
(FB) (Figure 10). β-Caryophyllene, one of the compounds in6 Evidence-Based Complementary and Alternative Medicine
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Figure7:β-caryophylleneactivatecaspase-3intwotumorcelllines.
The enzymatic activity of diﬀerent cell lines incubated with β-
caryophyllene (2.4e − 4μM) for 2hrs was assessed. Measurements
weretakenfollowing1020minofenzymaticreactioninvitro.Prein-
cubation with caspase-3 inhibitor (DEVD-CHO) eliminated any
development of caspase-3 activity.
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Figure 8: Comparison of the apoptogenic eﬀects of β-caryophyll-
ene and citral on BS-24-1 tumor cell lines. Enzymatic activity of
BS-24-1 incubated with β-caryophyllene (0.33μL/mL) and citral
(0.1μL/mL) for 2hrs. x-axis represents the time of the enzymatic
reaction in vitro in minutes. Preincubation with caspase-3 inhibitor
(DEVD-CHO) eliminated any development of caspase-3 activity.
the essential oil, is responsible for these eﬀects. Our results
agree with previous studies [16–20, 38] which indicated
that β-caryophyllene shows antiproliferative activity against
tumor cell lines. To the best of our knowledge, this is the ﬁrst
time that the function of an apoptosis-inducing agent was
assigned to β-caryophyllene. One of the main problems with
1234567
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Figure 9: BS-24-1 cells (1,000,000cells/mL) were incubated with
C. gileadensis stem and leaf extracts (6μL/mL) for 17h. DNA was
separated and analyzed on agarose gel. Lanes 1–7 and 11: H2O-
basedstemextract.Lanes8–10:H2O-basedleafextract.Lanes12–18
and22,ethanol-basedstemextract.Lanes19–21:ethanol-basedleaf
extract. Lanes 23 and 24: control cells treated with ethanol (0.05%)
and water.
1 ( M W ) 23456 123456
MoFir FB
Figure 10: MoFir and FB cells were incubated with C. gileadensis
extract (2.5μL/mL) for 24h. DNA was separated and analyzed on
agarose gel. Lanes 1 and 2: ethanol-based stem extract. Lane 3–
5: ethanol-based leaf extract. Lane 6: untreated cells with ethanol
(0.05%) alone.
compounds used for chemotherapy is that they are nonselec-
tive, namely, they kill normal cells as well as cancer cells [40].
Interestingly, the results in the current study indicated that
β-caryophyllene acts in a selective manner against tumor cell
lines and not against normal cells. Since β-caryophyllene is a
natural product used by humans on a daily basis [14, 15], it
maybereadilyacceptableasadietarysupplementwithmedi-
cinal values capable of eradicating tumor cells and, as such,
may protect against tumor development.
Abbreviations
BS-24-1: Mouse lymphoma cell line
EBV: Epstein-Barr virus
EtOH: Ethanol
FB: Normal human skin ﬁbroblasts
MoFir: Epstein-Barr virus-transformed human B
lymphocytes.Evidence-Based Complementary and Alternative Medicine 7
123 (MW)
Figure 11:BS-24-1cellswereincubatedwithC.gileadensisessential
oil for 24h. DNA was separated and analyzed on agarose gel. Lane
1: control-cells treated with ethanol (0.05%) alone. Lane 2: cells
incubated with 0.625μL/mL essential oil. Lane 3: cells incubated
with 1.25μL/mL essential oil.
1 23
Figure 12: Fragmentation of DNA in the presence of β-caryophyll-
ene.BS-24-1cellswereincubatedinthepresenceofβ-caryophyllene
in two combinations of time and concentrations. Lane 1: cells with
ethanol(0.05%)alone.Lane2:cellsincubatedfor24hwith2.4μlM.
Lane 3, cells incubated for 2h with 9.6μM β-caryophyllene.
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